Taiwan draws foreign biotech IPOs


Vibrant scene: Taiwan is home to the largest number of listed biotechnology companies in Asia with the sector expanding due to a well-educated workforce, historic appetite for high-tech industries and government support. – AFP

Singapore firm working on experimental cancer drugs plans listing by end-May

HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , IPO , cancer , drugs , Taiwan

Next In Business News

Felda proposes establishing national taskforce to develop oil palm carbon framework
Bursa Malaysia remains lower at midday, KLCI down 0.54%
MUI Properties to buy Ijok land for RM605mil
Geohan sets sights on Singapore to drive regional growth
DRB-Hicom shares up on revised US$110.62mil purchase price for Spirit MY
AirAsia X eyes second-tier cities and broader Europe-Central Asia connectivity next year
Japan's Nikkei skids in subdued Asia as bets of rate hike grow
Oil prices head for 2% weekly gain as Fed hopes boost market, Venezuela tensions loom
Ringgit opens stronger at RM4.10 vs greenback
Subdued trading on Bursa continues as traders await Fed rate decision

Others Also Read